Description

Calvenza-03 EIV/EHV is an Equine Rhinopneumonitis-Influenza Killed Virus Vaccine.

Features

Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95).

Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93).

Unique EHV-1 equine respiratory origin isolate.

Stimulates antibody to EHV-1 & EHV-4.

Novel adjuvant.

Safe, all killed vaccine.

Includes innovative pliable nasal applicator.

Benefits

Flexible dose administration.

Three dose regimen conforms to AAEP recommendations.

No reversion to virulence concern.

Minimal vaccine site reactions.

Dosage & Administration

Using aseptic technique inoculate horses IM with a 2 mL dose. Administer a second 2 mL dose IM in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks either IM or IN. Revaccinate annually and prior to anticipated exposure either IM or IN.

Precautions

Store at a temperature between 35∞ - 45∞ F (2∞ - 7∞ C). Protect from freezing. Shake well before using. Do not vaccinate within 21 days of slaughter.
Antidote: Epinephrine.

Highlights

• First killed virus vaccine to include the latest North American strain to be identified (Ohio/2003).

• Relevant types, quantities of EIV & EHV antigens with a novel adjuvant.

• Flexible routes of administration.

• Safe for use in pregnant mares.

Uses

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) and by equine influenza type A₂ virus.

Warning

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Packaging Options (top)

Contact Information For Calvenza-03 EIV/EHV (top)

Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506
800-821-7467 Information
800-325-9167 Sales
816-236-2717
email: marion.tittle@boehringer-ingelheim.com
internet: http://www.bi-vetmedica.com

General Product Information Documents (top)

Product Image for Calvenza-03 EIV/EHV (top)